Drugs Information: Binimetinib
Basic Information
|
||
| ID | DDInter210 | |
| Drug Type | small molecule | |
| Molecular Formula | C17H15Brf2N4O3 | |
| Molecular Weight | 441.232 | |
| Description | Binimetinib is a medication used to treat metastatic melanoma with specific mutations. | |
| ATC Classification | L01XE41 | |
| IUPAC Name | 5-[(4-Bromo-2-Fluorophenyl)Amino]-4-Fluoro-N-(2-Hydroxyethoxy)-1-Methyl-1H-1,3-Benzodiazole-6-Carboxamide | |
| InChI | Inchi=1S/C17H15Brf2N4O3/C1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/H2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) | |
| InChI Key | ACWZRVQXLIRSDF-UHFFFAOYSA-N | |
| Canonical SMILES | CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Binimetinib
| Severity level | ID | Name | Mechanism | Detail |
|---|